{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-004059","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2024-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.425912+00:00","generated_at":"2026-05-31T23:41:24.788883+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"VolitionRx shareholders approve 75% increase in authorized shares to 175M and new equity plan","bullets":["Authorized shares increased from 100M to 175M (75% increase), effective July 2, 2024 via Certificate of Amendment.","2024 Stock Incentive Plan adopted, reserving 7.5M shares for future equity awards to employees, directors, and consultants.","Six director nominees elected; auditor Sadler, Gibb & Associates ratified; say-on-pay advisory vote passed.","All five stockholder proposals at annual meeting passed; 49.0M of 82.8M shares outstanding were voted.","Both the share increase and equity plan were stockholder-approved and immediately effective."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-004059","json":"https://secwatch.observer/filing/0001477932-24-004059.json","markdown":"https://secwatch.observer/filing/0001477932-24-004059.md","text":"https://secwatch.observer/filing/0001477932-24-004059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/0001477932-24-004059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:41:24.788883+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}